Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study-Reference-Cited by-同舟云学术

Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study

Published:2022-11 Issue: Volume:175 Page:224-235
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Müller-Jensen Leonie,Zierold Sarah,Versluis Judith M.^ORCID,Boehmerle Wolfgang^ORCID,Huehnchen Petra,Endres Matthias,Mohr Raphael,Compter Annette,Blank Christian U.,Hagenacker Tim^ORCID,Meier Friedegund^ORCID,Reinhardt Lydia,Gesierich Anja,Salzmann Martin^ORCID,Hassel Jessica C.^ORCID,Ugurel Selma,Zimmer Lisa^ORCID,Banks Patricia,Spain Lavinia,Soon Jennifer A.,Enokida Tomohiro,Tahara Makoto,Kähler Katharina C.,Seggewiss-Bernhardt Ruth^ORCID,Harvey Catriona^ORCID,Long Georgina V.^ORCID,Schöberl Florian,von Baumgarten Louisa,Hundsberger Thomas,Schlaak Max,French Lars E.^ORCID,Knauss Samuel,Heinzerling Lucie M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Adjuvant pembrolizumab versus placebo in resected stage III melanoma;Eggermont;N Engl J Med,2018

2. Overall survival with combined nivolumab and ipilimumab in advanced melanoma;Wolchok;N Engl J Med,2017

3. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance;Martins;Nat Rev Clin Oncol,2019

4. Neurological adverse events associated with immune checkpoint inhibitors: review of the literature;Cuzzubbo;Eur J Cancer,2017

5. Neurologic complications of immune checkpoint inhibitors;Hottinger;Curr Opin Neurol,2016

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospective cohort study;The Lancet Regional Health - Europe;2024-09

2. Neurological Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors;Biomedicines;2024-06-13

3. Cerebral¹⁸F-FDG PET/CT Metabolism as Diagnostic Signature for Central Nervous System Toxicity After Immune Checkpoint Blockade Cancer Treatment;Journal of Nuclear Medicine;2024-05-02

4. Neurological Adverse Events Related to Immune Checkpoint Inhibitors: A Practical Review;Pharmaceuticals;2024-04-14

5. Potentially fatal complications of new systemic anticancer therapies: pearls and pitfalls in their initial management;Radiology and Oncology;2024-04-14